Get the scoop on our progress and newsworthy events.
Cognivia CEO, Dominique Demolle, to Speak at Panel Discussion on Innovative Placebo Response Analysis in CNS Trials
Cognivia is thrilled to announce that Dominique Demolle, CEO of Cognivia, has been cordially invited to participate in…
Dominique Demolle to Unveil Cognivia AI-powered Innovations at DPharm Conference
Dominique Demolle, CEO of Cognivia, is set to deliver a captivating presentation at the upcoming DPharm conference which is scheduled for…
What the FDA’s Final Guidance on Covariates Means for Fighting the Placebo Response in RCTs: Our Article Published in ACRP Journal
The recently released final guidance by the U.S. Food & Drug Administration (FDA) on “Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products” introduces a new framework that is poised to transform the way statistical analyses are conducted in RCTs.
There are currently no future events.
See our events archive for our previous event attendance.
Understand patient differences in your next clinical trial
Increase your trial’s success rates and bring new therapies to patients faster.
Tell us about your clinical trial below, and our team will be in touch.
"*" indicates required fields